Who are the Top 3 Biotech Takeover Targets?
Most investors thought 2018 would be a big year for mergers and acquisitions in the biopharma industry because of changes to the tax law, and so far they’ve been right.
The Home of the Life Sciences Industry
Explore Latest News
Ahead of the Takeda-Shire Takeover, Takeda Selling Chinese Joint Venture
With the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical pretty much a done-deal, Takeda appears to be getting its financial house in order before it closes.
- Sesen Bio Shares Plunge Despite Reporting Positive Interim Phase III Results
- Crowdsource Funding to Launch a Biotech: Is it as Crazy as it Sounds?
- Approved! FDA gives Dova Pharma’s Doptelet a Thumbs Up
- Celgene’s Deal Boss Golumbeski Made a Quiet Exit in April
- Allergan Draws on Another Aptinyx Compound to Complement its Phase III Depression Drug
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.